Routine use of concurrent fluoroscopic imaging during superficial endovenous interventions: A position statement of the International Union of Phlebology (UIP), the Australasian College of Phlebology (ACP), the Australia and New Zealand Society for Vascular Surgery (ANZSVS), the American Venous Forum (AVF), the American Vein and Lymphatic Society (AVLS), the European College of Phlebology (ECoP) and the Interventional Radiology Society of Australasia (IRSA).


Journal

Journal of vascular surgery. Venous and lymphatic disorders
ISSN: 2213-3348
Titre abrégé: J Vasc Surg Venous Lymphat Disord
Pays: United States
ID NLM: 101607771

Informations de publication

Date de publication:
11 2022
Historique:
received: 22 06 2022
accepted: 11 07 2022
pubmed: 16 8 2022
medline: 19 10 2022
entrez: 15 8 2022
Statut: ppublish

Résumé

International evidence-based guidelines recommend preoperative duplex ultrasound mapping in the assessment of chronic venous disease, and concurrent ultrasound imaging to guide superficial endovenous interventions such as endovenous laser ablation, radiofrequency ablation, cyanoacrylate adhesive closure, and sclerotherapy (ultrasound-guided sclerotherapy). Other imaging modalities such as venography, alone or in combination with computed tomography scan or magnetic resonance imaging, may be included in the preoperative assessment of a small and select group of patients to exclude central venous obstruction, certain deep venous pathologies, pelvic origin extrapelvic varices, and complex vascular malformations. The signatory scientific and medical societies recommend against the routine use of fluoroscopy and other radiation-based imaging in the investigation and treatment of superficial venous disease.

Identifiants

pubmed: 35970306
pii: S2213-333X(22)00350-X
doi: 10.1016/j.jvsv.2022.07.009
pii:
doi:

Substances chimiques

Cyanoacrylates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1198-1200

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Kurosh Parsi (K)

International Union of Phlebology (UIP); Australasian College of Phlebology (ACP). Electronic address: kparsi@sydneyskinandvein.com.au.

Peter Subramaniam (P)

Australia and New Zealand Society for Vascular Surgery (ANZSVS).

Alun H Davies (AH)

International Union of Phlebology (UIP); European College of Phlebology (ECoP).

Antonios Gasparis (A)

American Venous Forum (AVF).

Peter Gloviczki (P)

American Venous Forum (AVF).

William A Marston (WA)

American Venous Forum (AVF).

Mark Meissner (M)

International Union of Phlebology (UIP); American Venous Forum (AVF); American Vein and Lymphatic Society (AVLS).

Christopher Rogan (C)

Australasian College of Phlebology (ACP); Interventional Radiology Society of Australasia (IRSA).

Andre van Rij (A)

Australasian College of Phlebology (ACP).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH